These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15981821)

  • 1. E-cadherin negative primary small cell carcinoma of the breast.
    Adegbola T; Connolly CE; Mortimer G
    Am J Clin Pathol; 2005 May; 123(5):788. PubMed ID: 15981821
    [No Abstract]   [Full Text] [Related]  

  • 2. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
    Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
    Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of E-cadherin N-glycosylation profile in a mammary tumor model.
    Pinho SS; Osório H; Nita-Lazar M; Gomes J; Lopes C; Gärtner F; Reis CA
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1091-6. PubMed ID: 19159617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell carcinoma of the breast.
    Mirza IA; Shahab N
    Semin Oncol; 2007 Feb; 34(1):64-6. PubMed ID: 17270668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin expression in invasive breast cancer.
    Suciu C; Cîmpean AM; Mureşan AM; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2008; 49(4):517-23. PubMed ID: 19050801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
    Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
    Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of small cell carcinoma of the breast.
    Sadanaga N; Okada S; Shiotani S; Morita M; Kakeji Y; Kitamura K; Tamiya S; Sugimachi K; Maehara Y
    Oncol Rep; 2008 Apr; 19(4):981-5. PubMed ID: 18357385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary small cell carcinoma of the breast: report of a case].
    Qu LM; Zhao G; Zou YB; Song YE; Bi LR
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):120-1. PubMed ID: 21426813
    [No Abstract]   [Full Text] [Related]  

  • 10. Bilateral breast metastasis from small-cell carcinoma of the ovary.
    Cheng Z; Yin H; Du J; Yue X; Qian X; Liu B
    J Clin Oncol; 2008 Nov; 26(31):5129-30. PubMed ID: 18838706
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary carcinoma of breast with small-cell differentiation.
    Sridhar P; Matey P; Aluwihare N
    Breast; 2004 Apr; 13(2):149-51. PubMed ID: 15019697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cadherins and catenins in breast cancer.
    Cowin P; Rowlands TM; Hatsell SJ
    Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
    Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid transcription factor-1 and "basal marker"--expressing small cell carcinoma of the breast.
    Ersahin C; Bandyopadhyay S; Bhargava R
    Int J Surg Pathol; 2009 Oct; 17(5):368-72. PubMed ID: 19578049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
    Qureshi HS; Linden MD; Divine G; Raju UB
    Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin engagement provides a dominant stop signal for the migration of MDA-MB-468 breast carcinoma cells.
    Potthoff S; Entschladen F; Niggemann B; Zaenker KS; Lang K
    Breast Cancer Res Treat; 2007 Nov; 105(3):287-95. PubMed ID: 17171299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.
    Koo JS; Jung W; Jeong J
    Jpn J Clin Oncol; 2009 Sep; 39(9):560-8. PubMed ID: 19531543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of E-cadherin endocytosis by loss of protein phosphatase 2A expression in human breast cancers.
    Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2006 Oct; 349(1):255-60. PubMed ID: 16930554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry: a new approach for the molecular profiling of breast cancer.
    Lostumbo A; Mehta D; Setty S; Nunez R
    Exp Mol Pathol; 2006 Feb; 80(1):46-53. PubMed ID: 16271361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of cadherins in health and in developing breast cancer].
    Zasadkevich YM; Brilliant AA; Sazonov SV
    Arkh Patol; 2015; 77(3):57-64. PubMed ID: 26226783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.